Business

Statement re Possible Offer

Statement re Possible Offer.

articleCambridge Nutritional Sciences PlcOctober 19, 20094/company/cambridge-nutritional-sciences-plc/news/statement-re-possible-offer-64
Statement re Possible Offer

About this update from Cambridge Nutritional Sciences Plc

[{"type":"text","content":"\n RNS Number : 9598A Omega Diagnostics Group PLC 19 October 2009  \n \nOmega diagnostics PLC\n(\"Omega\" or the \"Company\")\n\nStatement re Possible Offer \n\nThe Company notes the recent movement in its share price and announces that it has received a preliminary approach. This approach may or may not lead to a business combination that may result in an offer for the Company. There is no certainty that the approach will result in an offer for the Company.\n\nA further announcement will be made in due course.\n \nRule 2.10 Requirement\n\nIn accordance with Rule 2.10 of the City Code on Takeovers and Mergers, Omega confirms that it currently has in issue 20,632,907 ordinary shares of 4p each. \nThe International Securities Identification Number for the ordinary shares is GB00B1VCP282.\n\nContact:\n\n\n\n\n\nOmega Diagnostics Group PLC  \n\n\nTel: 01259 763 030\n\n\n\n\nAndrew Shepherd, Chief Executive  \n\n\n\n\n\n\n\nKieron Harbinson, Group Finance Director  \n\n\nwww.omegadiagnostics.com\n\n\n\n\n\n\n\n\n\n\n\n\nCenkos Securities plc  \n\n\nTel: 020 7397 8900\n\n\n\n\nNicholas Wells\nElizabeth Bowman\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nWalbrook PR Limited\n\n\nTel: 020 7933 8780\n\n\n\n\nBen Knowles\n\n\nPaul McManus\n\n\[email protected]\nMob: 07900 346978\n\[email protected]\nMob: 07980 541893\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nDealing Disclosure Requirements:-\nUnder the provisions of Rule 8.3 of the City Code on Takeovers and Mergers (the \"Code\"), if any person is, or becomes, \"interested\" (directly or indirectly) in one per cent. or more of any class of \"relevant securities\" of the Company, all \"dealings\" in any \"relevant securities\" of that company (including by means of an option in respect of, or a derivative referenced to, any such relevant securities) must be publicly disclosed by no later than 3.30pm (London time) on the London business day following the date of the relevant transaction. This requirement will continue until the date on which any offer becomes, or is declared, unconditional as to acceptances, lapses or is otherwise withdrawn or on which the \"offer period\" otherwise ends. If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to a...

More updates from Cambridge Nutritional Sciences Plc